1. Companies

  2. Amblyotech

Amblyotech

Amblyotech

closed
Developer of novel electronic media therapies designed for the treatment of amblyopia and other ocular diseases.
Launch date
Market cap
-
Enterprise valuation
CAD2—3m (Dealroom.co estimates Jan 2018.)
Atlanta Georgia (HQ)
http://amblyotech.com
https://twitter.com/novartishttps://www.facebook.com/610959839003874
    • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$200k

Seed
N/A

$400k

Seed
*

N/A

Acquisition
Total FundingCAD818k

Related Content

Recent News about Amblyotech

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Amblyotech

Edit
Intellia Therapeutics
Intellia Therapeutics
exited
XOMA
XOMA
exited
Aduro BioTech
Aduro BioTech
exited
Ayala Pharmaceuticals
Ayala Pharmaceuticals
exited
Poseida Therapeutics
Poseida Therapeutics
exited
Immunitas Therapeutics
Immunitas Therapeutics
Dunad Therapeutics
Dunad Therapeutics
Medtech Africa
Medtech Africa